NanoViricides to Present at D. Boral Capital Global Conference 2026
May 7, 2026 — NanoViricides (NNVC) to present at D. Boral Capital Global Conference on May 7, 2026. CEO Anil Diwan to hold one-on-one meetings. Lead drug NV-387 targets RSV, COVID, influenza, and Monkeypox.